Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma.

Bronchoalveolar lavage (BAL) leukocyte-secreted cytokines are considered to be important mediators of the inflammatory and allergic reactions in the lung. This study examines quantitative changes in the level of tumor necrosis factor-alpha (TNF alpha) and interferon-gamma (IFN gamma) production in BAL cell cultures derived from patients (n = 11) with bronchial asthma. The secretion of TNF alpha and IFN gamma was determined in intact (unstimulated) and phytohemagglutinin/phorbol myristate acetate (PHA + PMA)-stimulated BAL leukocyte cultures and compared with that in control cultures. In all patients studied, the background and PHA + PMA-induced secretion of TNF alpha and IFN gamma was significantly (p < 0.001) higher than that in parallel control cultures. In contrast to BAL cell preparations, the capacity of TNF alpha and IFN gamma secretion by patients' peripheral blood mononuclear cells (PBMC) did not differ from that of control subjects. High spontaneous release of TNF alpha and IFN gamma by patients' BAL leukocytes, but not PBMC, suggest that in the pathophysiology of bronchial asthma, these cytokines may act as local pathogenic agents in the lung.

[1]  A. Inglot,et al.  Inhaled natural human interferon alpha induces bronchospastic reactions in asthmatics. , 1992, Archivum immunologiae et therapiae experimentalis.

[2]  A. Capron,et al.  Increased secretion of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. , 1991, The Journal of allergy and clinical immunology.

[3]  A. B. Kay,et al.  Asthma and inflammation. , 1991, The Journal of allergy and clinical immunology.

[4]  M. Capobianchi,et al.  Selective deficiency of interferon‐gamma production in the hyper‐IgE syndrome. Relationship to in vitro IgE synthesis , 1991, Clinical and experimental immunology.

[5]  T. Takishima,et al.  Nonadrenergic inhibitory nervous systems in the airways. , 1991, The American review of respiratory disease.

[6]  D. Blanchard,et al.  Release of tumor necrosis factor by human polymorphonuclear leukocytes. , 1990, Blood.

[7]  J. Pober,et al.  IFN-gamma enhances endothelial activation induced by tumor necrosis factor but not IL-1. , 1990, Journal of immunology.

[8]  R. Freeman,et al.  In-vitro production of TNF-α in blood samples , 1990, The Lancet.

[9]  A. Inglot,et al.  Hyporesponsiveness of human alveolar leukocytes to interferon-alpha and interferon-gamma inducers. , 1990, Immunobiology.

[10]  N. Shibata,et al.  Enhanced expression of the tumour necrosis factor/cachectin gene in peripheral blood mononuclear cells from patients with systemic vasculitis , 1990, Clinical and experimental immunology.

[11]  C. Corrigan,et al.  CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. , 1990, The American review of respiratory disease.

[12]  J. Pujol,et al.  Interleukin-1 release by alveolar macrophages in asthmatic patients and healthy subjects. , 1990, International archives of allergy and applied immunology.

[13]  R. Baughman,et al.  Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis. , 1990, The Journal of laboratory and clinical medicine.

[14]  J. Pujol,et al.  Identification of an alveolar macrophage-derived activity in bronchial asthma that enhances leukotriene C4 generation by human eosinophils stimulated by ionophore A23187 as a granulocyte-macrophage colony-stimulating factor. , 1989, The American review of respiratory disease.

[15]  R. Jankowska,et al.  Interferon synthesis by peripheral blood leukocytes of patients with bronchial asthma. , 1989, Archivum immunologiae et therapiae experimentalis.

[16]  A. Wardlaw,et al.  The activated eosinophil in allergy and asthma. , 1989, Progress in clinical and biological research.

[17]  J. Banchereau,et al.  IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma. , 1988, Journal of immunology.

[18]  K. Chung,et al.  Inflammatory mediators and asthma. , 1988, Pharmacological reviews.

[19]  A. Sypuła,et al.  Production of interferon by leukocytes from patients with atopic and nonatopic asthma. , 1988, Archivum immunologiae et therapiae experimentalis.

[20]  E. Unanue,et al.  Regulation of macrophage Ia expression in mice with severe combined immunodeficiency: induction of Ia expression by a T cell-independent mechanism. , 1986, Journal of immunology.

[21]  J. Tavernier,et al.  Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma. , 1986, Journal of immunology.

[22]  J. Vilček,et al.  Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor. , 1986, Journal of immunology.

[23]  R. Crystal,et al.  Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. , 1985, The Journal of clinical investigation.

[24]  D. A. Flick,et al.  Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. , 1984, Journal of immunological methods.

[25]  P. Godard,et al.  Functional assessment of alveolar macrophages: comparison of cells from asthmatics and normal subjects. , 1982, The Journal of allergy and clinical immunology.